Abstract
Cannabinoids inhibit motility and secretion in the intestine. They are now assigned the additional task of curbing excessive inflammation, suggesting that drugs targeting the endogenous cannabinoid system could be exploited for inflammatory bowel disease.
MeSH terms
-
Animals
-
Cannabinoid Receptor Modulators / physiology
-
Cannabinoids / pharmacology*
-
Cannabinoids / therapeutic use
-
Gastrointestinal Motility / drug effects
-
Humans
-
Inflammatory Bowel Diseases / drug therapy*
-
Inflammatory Bowel Diseases / etiology
-
Intestines / drug effects*
-
Mice
Substances
-
Cannabinoid Receptor Modulators
-
Cannabinoids